4263 — SUSMED Balance Sheet
0.000.00%
Last trade - 00:00Annual balance sheet for SUSMED, fiscal year end - June 30th, JPY millions except per share, conversion factor applied.
2022 June 30th | 2023 June 30th | 2024 June 30th | 2025 June 30th | 2026 June 30th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | Yuho | Yuho | Yuho | Yuho | Yuho |
| Standards: | JAS | JAS | JAS | JAS | JAS |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Cash and Short Term Investments | 4,904 | 5,049 | 4,847 | 4,398 | 3,698 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 9.57 | 10.9 | 20.2 | 15.4 | 274 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 4,936 | 5,085 | 4,898 | 4,463 | 4,028 |
| Net Property, Plant And Equipment | 0 | 0 | 0 | 0 | 6.4 |
| Net Intangible Assets | |||||
| Other Long Term Assets | |||||
| Total Assets | 4,944 | 5,101 | 4,932 | 4,503 | 4,218 |
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 87.7 | 225 | 321 | 126 | 148 |
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 93.3 | 230 | 328 | 132 | 148 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Treasury Stock | |||||
| Other Equity | |||||
| Total Equity | 4,850 | 4,871 | 4,604 | 4,371 | 4,070 |
| Total Liabilities & Shareholders' Equity | 4,944 | 5,101 | 4,932 | 4,503 | 4,218 |
| Total Common Shares Outstanding |